Cannabics Pharmaceuticals Pink Sheet Forward View
| CNBX Stock | USD 0.0002 0.00 0.00% |
Cannabics Pink Sheet outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Cannabics Pharmaceuticals' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Cannabics Pharmaceuticals hype-based prediction, you can estimate the value of Cannabics Pharmaceuticals from the perspective of Cannabics Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Cannabics Pharmaceuticals on the next trading day is expected to be 0.0003 with a mean absolute deviation of 0.000049 and the sum of the absolute errors of 0. Cannabics Pharmaceuticals after-hype prediction price | USD 2.28E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cannabics |
Cannabics Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Cannabics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cannabics using various technical indicators. When you analyze Cannabics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cannabics Pharmaceuticals Naive Prediction Price Forecast For the 17th of February 2026
Given 90 days horizon, the Naive Prediction forecasted value of Cannabics Pharmaceuticals on the next trading day is expected to be 0.0003 with a mean absolute deviation of 0.000049, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Cannabics Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cannabics Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cannabics Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Cannabics Pharmaceuticals | Cannabics Pharmaceuticals Price Prediction | Research Analysis |
Cannabics Pharmaceuticals Forecasted Value
In the context of forecasting Cannabics Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cannabics Pharmaceuticals' downside and upside margins for the forecasting period are 0.000002 and 18.34, respectively. We have considered Cannabics Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cannabics Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Cannabics Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 98.8203 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.1462 |
| SAE | Sum of the absolute errors | 0.003 |
Predictive Modules for Cannabics Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cannabics Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cannabics Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Cannabics Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cannabics Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Cannabics Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cannabics Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Cannabics Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cannabics Pharmaceuticals' historical news coverage. Cannabics Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 18.34, respectively. We have considered Cannabics Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cannabics Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Cannabics Pharmaceuticals is based on 3 months time horizon.
Cannabics Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cannabics Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cannabics Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cannabics Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.41 | 18.34 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0002 | 0.0002 | 14.10 |
|
Cannabics Pharmaceuticals Hype Timeline
Cannabics Pharmaceuticals is currently traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cannabics is forecasted to increase in value after the next headline, with the price projected to jump to 2.28E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is estimated to be 14.1%, whereas the daily expected return is currently at 0.41%. The volatility of related hype on Cannabics Pharmaceuticals is about 5557575.76%, with the expected price after the next announcement by competition of 0.00. Cannabics Pharmaceuticals currently holds 1.6 M in liabilities with Debt to Equity (D/E) ratio of 0.48, which is about average as compared to similar companies. Cannabics Pharmaceuticals has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cannabics Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Cannabics Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannabics Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannabics to invest in growth at high rates of return. When we think about Cannabics Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Cannabics Pharmaceuticals to cross-verify your projections.Cannabics Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Cannabics Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Cannabics Pharmaceuticals' future price movements. Getting to know how Cannabics Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cannabics Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GNLKQ | Genelink | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ENDV | Endonovo Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MCRT | Microart | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RVLP | RVL Pharmaceuticals PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ACUR | Acura Pharmaceuticals | 0.00 | 1 per month | 0.00 | 0.12 | 0.00 | 0.00 | 375.00 | |
| TNPH | Tianan Pharmaceutical Co | (0) | 2 per month | 0.00 | 0.13 | 0.00 | 0.00 | 317.02 | |
| ITMC | Itoco Inc | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 100.00 | |
| FLHLF | Filament Health Corp | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 99.50 | |
| AFFY | Affymax | 0.00 | 0 per month | 15.52 | 0.06 | 50.00 | (38.46) | 205.59 | |
| NSPDF | Naturally Splendid Enterprises | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Cannabics Pharmaceuticals
For every potential investor in Cannabics, whether a beginner or expert, Cannabics Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cannabics Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cannabics. Basic forecasting techniques help filter out the noise by identifying Cannabics Pharmaceuticals' price trends.Cannabics Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cannabics Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Cannabics Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cannabics Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cannabics Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Cannabics Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cannabics Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cannabics Pharmaceuticals pink sheet market strength indicators, traders can identify Cannabics Pharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 |
Cannabics Pharmaceuticals Risk Indicators
The analysis of Cannabics Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cannabics Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cannabics pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 10.34 | |||
| Semi Deviation | 11.46 | |||
| Standard Deviation | 18.08 | |||
| Variance | 326.99 | |||
| Downside Variance | 661.59 | |||
| Semi Variance | 131.42 | |||
| Expected Short fall | (35.00) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cannabics Pharmaceuticals
The number of cover stories for Cannabics Pharmaceuticals depends on current market conditions and Cannabics Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cannabics Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cannabics Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.